# Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan

> **NCT01019408** · PHASE4 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 163 (actual)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT01019408
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-11
- **Primary completion:** 1995-01
- **Final completion:** 1995-01
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2009-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019408, "Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01019408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*